Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Daniel Scott Ory currently holds 950,000 shares of Editas Medicine, Inc. (EDIT), valued at approximately $0. This represents their equity stake as EVP, Chief Medical Officer.
Based on SEC Form 4 filings, Daniel Scott Ory has been a net neutral trader of EDIT stock. They have purchased $0 and sold $0 worth of shares.
Daniel Scott Ory's most recent insider trade was on Sep 8, 2026, when they sold 950,000 shares at $0.00 per share.
Daniel Scott Ory serves as EVP, Chief Medical Officer at Editas Medicine, Inc. (EDIT). They have executed 1 insider transactions totaling $0 over their tenure at the company.
Daniel Scott Ory holds the position of EVP, Chief Medical Officer at Editas Medicine, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 1 years and currently hold a stake valued at $0.
Daniel Scott Ory has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Daniel Scott Ory was on Sep 8, 2026, when they purchased $0 worth of EDIT shares. This transaction involved 950,000 shares at N/A per share.
Daniel Scott Ory currently owns 950,000 shares of Editas Medicine, Inc. (EDIT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Daniel Scott Ory's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Daniel Scott Ory has 1 Form 4 filings on record as an insider at Editas Medicine, Inc..
Set alerts for Daniel Scott Ory and 40,000+ other insiders.